Novel tight binding PETT, HEPT and DABO-based non-nucleoside inhibitors of HIV-1 reverse transcriptase

By D'cruz Osmond J.   Uckun Fatih M.  

Journal of Enzyme Inhibition and Medicinal Chemistry, Vol. 21, Iss. 4, 2006-08 ,pp. : 329-350

Informa Healthcare

Access to resources Recommend Favorite

Arylsulfone-based HIV-1 non-nucleoside reverse transcriptase inhibitors

By Famiglini Valeria   Coluccia Antonio   Brancale Andrea   Pelliccia Sveva   La Regina Giuseppe   Silvestri Romano  

Future Medicinal Chemistry, Vol. 5, Iss. 18, 2013-12 ,pp. : 2141-2156

Future Science

Access to resources Recommend Favorite

Investigation of Novel Lipid-Functionalized PNA Monomers as Potential HIV-1 Non-Nucleoside Reverse Transcriptase and/or Integrase Inhibitors

By Thomas Michael   Maga Giovanni   Mouscadet Jean-François   Howarth Nicola  

Nucleosides, Nucleotides & Nucleic Acids, Vol. 26, Iss. 8-9, 2007-08 ,pp. : 1063-1066

Taylor & Francis Ltd

Access to resources Recommend Favorite

Non-nucleoside inhibitors of the hepatitis C virus NS5B polymerase: discovery of benzimidazole 5-carboxylic amide derivatives with low-nanomolar potency

By Beaulieu P.L.   Bos M.   Bousquet Y.   DeRoy P.   Fazal G.   Gauthier J.   Gillard J.   Goulet S.   McKercher G.   Poupart M.-A.   Valois S.   Kukolj G.  

Bioorganic and Medicinal Chemistry Letters, Vol. 14, Iss. 4, 2004-02 ,pp. : 967-971

Elsevier

Access to resources Recommend Favorite

Human Serum Albumin Binding of Novel Antiretroviral Nucleoside Derivatives of AZT

By Quevedo M.A.   Moroni G.N.   Briñón M.C.  

Biochemical and Biophysical Research Communications, Vol. 288, Iss. 4, 2001-11 ,pp. : 954-960

Elsevier

Access to resources Recommend Favorite